Haisco Pharmaceutical Group (002653.SZ) has granted 5.8 million restricted shares.

Haisco Pharmaceutical Group (002653.SZ) announced that the Board of Directors believes that the conditions for granting the restricted stock incentive plan for 2024 have been met. They have agreed to designate September 19, 2024 as the grant date, and to grant 5.8 million shares of restricted stock to six incentive recipients who meet the granting conditions. The grant price for the restricted stock is 13.955 yuan per share.